Through the merger of two major pharmaceutical companies with Japanese origin, completed in April 2007, Daiichi Sankyo strengthened its position as the number one pharmaceutical company by sales in Japan and as one of the 20 leading global pharmaceutical concerns. On the way to become a “Global Pharma Innovator”, the business mission is to focus on the company’s research activities to develop and commercialise innovative first and/or best in class products.

The current Daiichi Sankyo product range is focused on the treatment of cardiovascular diseases and diabetes.

Daiichi Sankyo Facts:

• Number one pharmaceutical company by sales in theJapanese market
• First company to develop a statin for hyperlipidaemia
• First company to develop a glitazone for diabetes
• 6,4 billion of worldwide net sales
• 17% global net sales invested in R&D
• One of the 20 leading global pharmaceutical companies
• 15,400 employees around the world
• 1,800 employees in Europe

AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2007, Boehringer Ingelheim posted net sales of 10.9 billion euro while spending one fifth of net sales on research and development in its largest business segment Prescription Medicines.

For more information please visit www.boehringer-ingelheim.com

Bristol-Myers Squibb is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life. Bristol-Myers Squibb's employees are dedicated to discovering, developing and providing innovative medicines and other products that address significant needs of millions of people worldwide.